ARTICLE | Financial News
Akari raises $17.4M follow-on
November 3, 2017 6:32 AM UTC
On Oct. 18, autoimmune and inflammatory disease company Akari Therapeutics plc (NASDAQ:AKTX) raised $17.4 million through the sale of 3.5 million ADSs at $5 per share in a follow-on underwritten by C...
BCIQ Company Profiles